

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.29441486 |
| 2 | * tricarboxylic acid cycle (GO:0006099) | 5.98240712 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 5.73848624 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.73848624 |
| 5 | proteasome assembly (GO:0043248) | 5.66539375 |
| 6 | lysine catabolic process (GO:0006554) | 5.41467142 |
| 7 | lysine metabolic process (GO:0006553) | 5.41467142 |
| 8 | oxidative phosphorylation (GO:0006119) | 5.15077818 |
| 9 | * respiratory electron transport chain (GO:0022904) | 4.93676135 |
| 10 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.81352147 |
| 11 | * electron transport chain (GO:0022900) | 4.79890803 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.77328128 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 4.77328128 |
| 14 | NADH metabolic process (GO:0006734) | 4.75594449 |
| 15 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.71330322 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.67318895 |
| 17 | L-phenylalanine metabolic process (GO:0006558) | 4.67318895 |
| 18 | glyoxylate metabolic process (GO:0046487) | 4.65632207 |
| 19 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.49893909 |
| 20 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.49559034 |
| 21 | succinate metabolic process (GO:0006105) | 4.48422950 |
| 22 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.48345397 |
| 23 | fatty acid beta-oxidation (GO:0006635) | 4.42557070 |
| 24 | negative regulation of ligase activity (GO:0051352) | 4.37114316 |
| 25 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.37114316 |
| 26 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.31201241 |
| 27 | oxaloacetate metabolic process (GO:0006107) | 4.29711485 |
| 28 | respiratory chain complex IV assembly (GO:0008535) | 4.27860370 |
| 29 | 2-oxoglutarate metabolic process (GO:0006103) | 4.26347179 |
| 30 | cellular ketone body metabolic process (GO:0046950) | 4.25632850 |
| 31 | branched-chain amino acid catabolic process (GO:0009083) | 4.25176098 |
| 32 | aspartate family amino acid catabolic process (GO:0009068) | 4.25064377 |
| 33 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.20062753 |
| 34 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.11785447 |
| 35 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.11785447 |
| 36 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.11785447 |
| 37 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.11051446 |
| 38 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.11051446 |
| 39 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.10226696 |
| 40 | ribosome assembly (GO:0042255) | 4.07865207 |
| 41 | aromatic amino acid family catabolic process (GO:0009074) | 4.03859848 |
| 42 | acetyl-CoA metabolic process (GO:0006084) | 3.97048438 |
| 43 | fatty acid oxidation (GO:0019395) | 3.95592837 |
| 44 | chaperone-mediated protein transport (GO:0072321) | 3.94916868 |
| 45 | fatty acid catabolic process (GO:0009062) | 3.94420739 |
| 46 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.93497032 |
| 47 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.93497032 |
| 48 | aldehyde catabolic process (GO:0046185) | 3.92104904 |
| 49 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.91692221 |
| 50 | tricarboxylic acid metabolic process (GO:0072350) | 3.91171563 |
| 51 | lipid oxidation (GO:0034440) | 3.90115726 |
| 52 | branched-chain amino acid metabolic process (GO:0009081) | 3.88473735 |
| 53 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.85425144 |
| 54 | valine metabolic process (GO:0006573) | 3.84833963 |
| 55 | carnitine shuttle (GO:0006853) | 3.82764224 |
| 56 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.82582424 |
| 57 | fatty acid transmembrane transport (GO:1902001) | 3.79100380 |
| 58 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.78851938 |
| 59 | cytochrome complex assembly (GO:0017004) | 3.77749710 |
| 60 | kynurenine metabolic process (GO:0070189) | 3.77383067 |
| 61 | establishment of integrated proviral latency (GO:0075713) | 3.76104963 |
| 62 | positive regulation of ligase activity (GO:0051351) | 3.71744743 |
| 63 | short-chain fatty acid metabolic process (GO:0046459) | 3.71115726 |
| 64 | ketone body metabolic process (GO:1902224) | 3.70773522 |
| 65 | amino-acid betaine metabolic process (GO:0006577) | 3.69645358 |
| 66 | heart contraction (GO:0060047) | 3.66275029 |
| 67 | heart process (GO:0003015) | 3.66275029 |
| 68 | IMP biosynthetic process (GO:0006188) | 3.65764039 |
| 69 | protein complex biogenesis (GO:0070271) | 3.65656520 |
| 70 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.64466876 |
| 71 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.63767057 |
| 72 | ATP biosynthetic process (GO:0006754) | 3.62031743 |
| 73 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.61216624 |
| 74 | monocarboxylic acid catabolic process (GO:0072329) | 3.60121962 |
| 75 | carnitine metabolic process (GO:0009437) | 3.58871998 |
| 76 | cysteine metabolic process (GO:0006534) | 3.57279683 |
| 77 | regulation of triglyceride catabolic process (GO:0010896) | 3.55383653 |
| 78 | alpha-linolenic acid metabolic process (GO:0036109) | 3.53027377 |
| 79 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.52050257 |
| 80 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.51331360 |
| 81 | purine nucleobase biosynthetic process (GO:0009113) | 3.50785217 |
| 82 | rRNA modification (GO:0000154) | 3.50410224 |
| 83 | tryptophan catabolic process (GO:0006569) | 3.48616436 |
| 84 | indole-containing compound catabolic process (GO:0042436) | 3.48616436 |
| 85 | indolalkylamine catabolic process (GO:0046218) | 3.48616436 |
| 86 | cullin deneddylation (GO:0010388) | 3.47412250 |
| 87 | regulation of coenzyme metabolic process (GO:0051196) | 3.43890502 |
| 88 | regulation of cofactor metabolic process (GO:0051193) | 3.43890502 |
| 89 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.43273903 |
| 90 | termination of RNA polymerase III transcription (GO:0006386) | 3.36617341 |
| 91 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.36617341 |
| 92 | regulation of ligase activity (GO:0051340) | 3.35893657 |
| 93 | aerobic respiration (GO:0009060) | 3.35146509 |
| 94 | tryptophan metabolic process (GO:0006568) | 3.34774838 |
| 95 | sulfur amino acid catabolic process (GO:0000098) | 3.34321103 |
| 96 | protein neddylation (GO:0045116) | 3.32767687 |
| 97 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.32190590 |
| 98 | bile acid biosynthetic process (GO:0006699) | 3.31510334 |
| 99 | IMP metabolic process (GO:0046040) | 3.31478582 |
| 100 | sarcomere organization (GO:0045214) | 3.28481108 |
| 101 | protein deneddylation (GO:0000338) | 3.26709933 |
| 102 | alpha-amino acid catabolic process (GO:1901606) | 3.26196441 |
| 103 | regulation of cellular amine metabolic process (GO:0033238) | 3.23221214 |
| 104 | regulation of sequestering of triglyceride (GO:0010889) | 3.23046802 |
| 105 | organic acid catabolic process (GO:0016054) | 3.19387934 |
| 106 | carboxylic acid catabolic process (GO:0046395) | 3.19387934 |
| 107 | protein targeting to mitochondrion (GO:0006626) | 3.17564814 |
| 108 | muscle filament sliding (GO:0030049) | 3.17248921 |
| 109 | actin-myosin filament sliding (GO:0033275) | 3.17248921 |
| 110 | regulation of mitochondrial translation (GO:0070129) | 3.16355549 |
| 111 | AMP metabolic process (GO:0046033) | 3.14503519 |
| 112 | cellular amino acid catabolic process (GO:0009063) | 3.13593929 |
| 113 | quinone biosynthetic process (GO:1901663) | 3.13580175 |
| 114 | ubiquinone biosynthetic process (GO:0006744) | 3.13580175 |
| 115 | nucleobase biosynthetic process (GO:0046112) | 3.12946227 |
| 116 | establishment of viral latency (GO:0019043) | 3.12823674 |
| 117 | ethanol oxidation (GO:0006069) | 3.12675863 |
| 118 | NAD metabolic process (GO:0019674) | 3.12333247 |
| 119 | negative regulation of protein ubiquitination (GO:0031397) | 3.11742891 |
| 120 | acyl-CoA metabolic process (GO:0006637) | 3.11518612 |
| 121 | thioester metabolic process (GO:0035383) | 3.11518612 |
| 122 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.10283279 |
| 123 | positive regulation of cell cycle arrest (GO:0071158) | 3.09857568 |
| 124 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.08283648 |
| 125 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.08221815 |
| 126 | rRNA methylation (GO:0031167) | 3.07992083 |
| 127 | carnitine transport (GO:0015879) | 3.07975316 |
| 128 | amino-acid betaine transport (GO:0015838) | 3.07975316 |
| 129 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.07920174 |
| 130 | ribosomal large subunit biogenesis (GO:0042273) | 3.07337574 |
| 131 | carnitine transmembrane transport (GO:1902603) | 3.05830516 |
| 132 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.02824967 |
| 133 | cellular respiration (GO:0045333) | 3.02702952 |
| 134 | inner mitochondrial membrane organization (GO:0007007) | 3.01634773 |
| 135 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.00778003 |
| 136 | biotin metabolic process (GO:0006768) | 3.00463168 |
| 137 | CENP-A containing nucleosome assembly (GO:0034080) | 3.00428029 |
| 138 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.99723164 |
| 139 | urea cycle (GO:0000050) | 2.99288145 |
| 140 | urea metabolic process (GO:0019627) | 2.99288145 |
| 141 | aromatic amino acid family metabolic process (GO:0009072) | 2.98692761 |
| 142 | pseudouridine synthesis (GO:0001522) | 2.97974435 |
| 143 | chromatin remodeling at centromere (GO:0031055) | 2.95681417 |
| 144 | DNA double-strand break processing (GO:0000729) | 2.95463885 |
| 145 | coenzyme catabolic process (GO:0009109) | 2.94346676 |
| 146 | protein localization to mitochondrion (GO:0070585) | 2.93873823 |
| 147 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.93491775 |
| 148 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.93491775 |
| 149 | serine family amino acid catabolic process (GO:0009071) | 2.93261984 |
| 150 | maturation of 5.8S rRNA (GO:0000460) | 2.92595221 |
| 151 | DNA deamination (GO:0045006) | 2.91432619 |
| 152 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.91205630 |
| 153 | response to mercury ion (GO:0046689) | 2.91137736 |
| 154 | dicarboxylic acid metabolic process (GO:0043648) | 2.88182179 |
| 155 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.87623214 |
| 156 | NADH dehydrogenase complex assembly (GO:0010257) | 2.87623214 |
| 157 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.87623214 |
| 158 | establishment of protein localization to mitochondrion (GO:0072655) | 2.87136059 |
| 159 | acylglycerol homeostasis (GO:0055090) | 2.86623962 |
| 160 | triglyceride homeostasis (GO:0070328) | 2.86623962 |
| 161 | ubiquinone metabolic process (GO:0006743) | 2.86024647 |
| 162 | homocysteine metabolic process (GO:0050667) | 2.85945386 |
| 163 | regulation of fatty acid oxidation (GO:0046320) | 2.85694885 |
| 164 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.84952473 |
| 165 | cofactor catabolic process (GO:0051187) | 2.84651697 |
| 166 | thioester biosynthetic process (GO:0035384) | 2.84307278 |
| 167 | mitochondrial transport (GO:0006839) | 2.82195499 |
| 168 | lactate metabolic process (GO:0006089) | 2.76041612 |
| 169 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.75718558 |
| 170 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.73285199 |
| 171 | cell cycle G1/S phase transition (GO:0044843) | 2.73285199 |
| 172 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.73086056 |
| 173 | hydrogen ion transmembrane transport (GO:1902600) | 2.71976647 |
| 174 | transcription from mitochondrial promoter (GO:0006390) | 2.69028187 |
| 175 | peptidyl-histidine modification (GO:0018202) | 2.68519755 |
| 176 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.65293405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.37884879 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.89710148 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.74554393 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.33597733 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.64271904 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.57538084 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.50372119 |
| 8 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.49843951 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.49788337 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.36981889 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.20099939 |
| 12 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.06335592 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.88982840 |
| 14 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.80884516 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.74181053 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.65359795 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.61285367 |
| 18 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.48836215 |
| 19 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.47208439 |
| 20 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.39667966 |
| 21 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.36763358 |
| 22 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.34282201 |
| 23 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.22365840 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.11546528 |
| 25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.04062595 |
| 26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.92472844 |
| 27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.92375611 |
| 28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.90903370 |
| 29 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.86463793 |
| 30 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.82569038 |
| 31 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.80959928 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71677773 |
| 33 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.69204741 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.68545675 |
| 35 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.66272526 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.65248274 |
| 37 | VDR_22108803_ChIP-Seq_LS180_Human | 1.58526669 |
| 38 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.55645487 |
| 39 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.54607245 |
| 40 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46457049 |
| 41 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.46324623 |
| 42 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.43071725 |
| 43 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.42228619 |
| 44 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.40674596 |
| 45 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.38302156 |
| 46 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.36689828 |
| 47 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.34802144 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.31236700 |
| 49 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30392094 |
| 50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30183768 |
| 51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28671405 |
| 52 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.24784202 |
| 53 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.24182110 |
| 54 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.21107009 |
| 55 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.20651904 |
| 56 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.20369583 |
| 57 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.19905611 |
| 58 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.19680342 |
| 59 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17399328 |
| 60 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.17117505 |
| 61 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15799602 |
| 62 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.14230216 |
| 63 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13087662 |
| 64 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.12984521 |
| 65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.12873611 |
| 66 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11575918 |
| 67 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.06793789 |
| 68 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.06620450 |
| 69 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.04804376 |
| 70 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.02945911 |
| 71 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.02824037 |
| 72 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.01524421 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.01520618 |
| 74 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.01498980 |
| 75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.01441236 |
| 76 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.00530037 |
| 77 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.00339366 |
| 78 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99514498 |
| 79 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99463073 |
| 80 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98670619 |
| 81 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.97797204 |
| 82 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.97724894 |
| 83 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97107224 |
| 84 | EWS_26573619_Chip-Seq_HEK293_Human | 0.95726126 |
| 85 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.92305559 |
| 86 | * ELF5_23300383_ChIP-Seq_T47D_Human | 0.90649502 |
| 87 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.90445039 |
| 88 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.90366987 |
| 89 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90064573 |
| 90 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.89337014 |
| 91 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.89174141 |
| 92 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.89167160 |
| 93 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.88663015 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88048442 |
| 95 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86369865 |
| 96 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.86144984 |
| 97 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.85712156 |
| 98 | AR_20517297_ChIP-Seq_VCAP_Human | 0.84620043 |
| 99 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.83978231 |
| 100 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.82307086 |
| 101 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81609710 |
| 102 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80239854 |
| 103 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80239854 |
| 104 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.79750992 |
| 105 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.79750992 |
| 106 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.79602794 |
| 107 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.79205443 |
| 108 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.78882209 |
| 109 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.78739240 |
| 110 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.78445651 |
| 111 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.78139319 |
| 112 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.78049707 |
| 113 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77593941 |
| 114 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.77012918 |
| 115 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.76930794 |
| 116 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76571546 |
| 117 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.76556123 |
| 118 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75940723 |
| 119 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.75808655 |
| 120 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.75808655 |
| 121 | FUS_26573619_Chip-Seq_HEK293_Human | 0.75619349 |
| 122 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.75130458 |
| 123 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.75060377 |
| 124 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.73353485 |
| 125 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.72648145 |
| 126 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.70256582 |
| 127 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.68946072 |
| 128 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.68870350 |
| 129 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.66114806 |
| 130 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.65882415 |
| 131 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.65546186 |
| 132 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.65490278 |
| 133 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.65413359 |
| 134 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.64963464 |
| 135 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.64637984 |
| 136 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.64239512 |
| 137 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.63313189 |
| 138 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.63247589 |
| 139 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.62407496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.44108708 |
| 2 | MP0005360_urolithiasis | 5.29243188 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.92877419 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 4.29020569 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.18603261 |
| 6 | MP0005365_abnormal_bile_salt | 3.82350126 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.20241911 |
| 8 | MP0003646_muscle_fatigue | 3.18150072 |
| 9 | MP0008058_abnormal_DNA_repair | 3.10054446 |
| 10 | * MP0006036_abnormal_mitochondrial_physio | 3.02989354 |
| 11 | MP0004084_abnormal_cardiac_muscle | 2.83961711 |
| 12 | MP0010094_abnormal_chromosome_stability | 2.78183599 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 2.73473105 |
| 14 | MP0003693_abnormal_embryo_hatching | 2.71676717 |
| 15 | MP0005332_abnormal_amino_acid | 2.69170067 |
| 16 | MP0003195_calcinosis | 2.67683470 |
| 17 | MP0000749_muscle_degeneration | 2.47261057 |
| 18 | MP0004215_abnormal_myocardial_fiber | 2.38431943 |
| 19 | MP0005330_cardiomyopathy | 2.37765347 |
| 20 | MP0004036_abnormal_muscle_relaxation | 2.36182521 |
| 21 | MP0003186_abnormal_redox_activity | 2.32914966 |
| 22 | MP0010329_abnormal_lipoprotein_level | 2.32028849 |
| 23 | MP0003718_maternal_effect | 2.30062037 |
| 24 | MP0003252_abnormal_bile_duct | 2.15759755 |
| 25 | MP0003941_abnormal_skin_development | 2.12991036 |
| 26 | MP0008007_abnormal_cellular_replicative | 2.04070856 |
| 27 | MP0005083_abnormal_biliary_tract | 2.02366062 |
| 28 | MP0003786_premature_aging | 1.98088841 |
| 29 | MP0009840_abnormal_foam_cell | 1.97501131 |
| 30 | MP0006035_abnormal_mitochondrial_morpho | 1.96065150 |
| 31 | MP0000751_myopathy | 1.94201066 |
| 32 | MP0004043_abnormal_pH_regulation | 1.90749040 |
| 33 | MP0001666_abnormal_nutrient_absorption | 1.89900538 |
| 34 | MP0004130_abnormal_muscle_cell | 1.85118730 |
| 35 | MP0002254_reproductive_system_inflammat | 1.83839222 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.83236711 |
| 37 | MP0003111_abnormal_nucleus_morphology | 1.81682534 |
| 38 | MP0001764_abnormal_homeostasis | 1.80939770 |
| 39 | MP0002972_abnormal_cardiac_muscle | 1.77474506 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.71510276 |
| 41 | MP0008775_abnormal_heart_ventricle | 1.66567697 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.65748706 |
| 43 | MP0002118_abnormal_lipid_homeostasis | 1.64693225 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.63717122 |
| 45 | MP0003077_abnormal_cell_cycle | 1.61312759 |
| 46 | MP0003221_abnormal_cardiomyocyte_apopto | 1.59229054 |
| 47 | MP0000372_irregular_coat_pigmentation | 1.59040050 |
| 48 | MP0004147_increased_porphyrin_level | 1.56465417 |
| 49 | MP0002269_muscular_atrophy | 1.56367018 |
| 50 | MP0005451_abnormal_body_composition | 1.54228837 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.52557484 |
| 52 | MP0000609_abnormal_liver_physiology | 1.52321459 |
| 53 | MP0004087_abnormal_muscle_fiber | 1.50191045 |
| 54 | MP0005266_abnormal_metabolism | 1.47492788 |
| 55 | MP0005620_abnormal_muscle_contractility | 1.46075004 |
| 56 | MP0005670_abnormal_white_adipose | 1.41307789 |
| 57 | * MP0005385_cardiovascular_system_phenoty | 1.40301893 |
| 58 | * MP0001544_abnormal_cardiovascular_syste | 1.40301893 |
| 59 | MP0008932_abnormal_embryonic_tissue | 1.40280474 |
| 60 | MP0005636_abnormal_mineral_homeostasis | 1.35546725 |
| 61 | MP0009697_abnormal_copulation | 1.32512168 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.30816560 |
| 63 | MP0004019_abnormal_vitamin_homeostasis | 1.28199914 |
| 64 | MP0008057_abnormal_DNA_replication | 1.22597139 |
| 65 | MP0003011_delayed_dark_adaptation | 1.22405001 |
| 66 | MP0006138_congestive_heart_failure | 1.19490003 |
| 67 | MP0010630_abnormal_cardiac_muscle | 1.17769071 |
| 68 | MP0008872_abnormal_physiological_respon | 1.17471206 |
| 69 | MP0009785_altered_susceptibility_to | 1.16981252 |
| 70 | MP0005666_abnormal_adipose_tissue | 1.15408386 |
| 71 | MP0000750_abnormal_muscle_regeneration | 1.13389941 |
| 72 | MP0003137_abnormal_impulse_conducting | 1.12938817 |
| 73 | MP0005535_abnormal_body_temperature | 1.12134561 |
| 74 | MP0002106_abnormal_muscle_physiology | 1.11743668 |
| 75 | MP0005376_homeostasis/metabolism_phenot | 1.11494730 |
| 76 | MP0006072_abnormal_retinal_apoptosis | 1.11000114 |
| 77 | MP0002102_abnormal_ear_morphology | 1.10187608 |
| 78 | MP0002277_abnormal_respiratory_mucosa | 1.09442241 |
| 79 | MP0010234_abnormal_vibrissa_follicle | 1.08554353 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 1.08365070 |
| 81 | MP0000747_muscle_weakness | 1.08122285 |
| 82 | MP0002971_abnormal_brown_adipose | 1.07009418 |
| 83 | MP0005379_endocrine/exocrine_gland_phen | 1.06582422 |
| 84 | MP0001756_abnormal_urination | 1.05513016 |
| 85 | MP0009333_abnormal_splenocyte_physiolog | 1.04596652 |
| 86 | MP0002148_abnormal_hypersensitivity_rea | 1.04058259 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.99171466 |
| 88 | MP0002332_abnormal_exercise_endurance | 0.98376087 |
| 89 | MP0002006_tumorigenesis | 0.97038218 |
| 90 | MP0008877_abnormal_DNA_methylation | 0.95006581 |
| 91 | MP0005408_hypopigmentation | 0.94796715 |
| 92 | MP0004484_altered_response_of | 0.94754751 |
| 93 | MP0001661_extended_life_span | 0.94698281 |
| 94 | MP0000230_abnormal_systemic_arterial | 0.94343406 |
| 95 | MP0000598_abnormal_liver_morphology | 0.91395604 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.90081725 |
| 97 | MP0000343_altered_response_to | 0.89256547 |
| 98 | MP0002938_white_spotting | 0.88960421 |
| 99 | MP0006054_spinal_hemorrhage | 0.88899284 |
| 100 | MP0005395_other_phenotype | 0.88767039 |
| 101 | MP0002166_altered_tumor_susceptibility | 0.88161847 |
| 102 | MP0005084_abnormal_gallbladder_morpholo | 0.87993302 |
| 103 | MP0010352_gastrointestinal_tract_polyps | 0.86245358 |
| 104 | MP0006082_CNS_inflammation | 0.85175403 |
| 105 | MP0004085_abnormal_heartbeat | 0.84373308 |
| 106 | MP0005369_muscle_phenotype | 0.82431424 |
| 107 | MP0000759_abnormal_skeletal_muscle | 0.79789460 |
| 108 | MP0005671_abnormal_response_to | 0.79729953 |
| 109 | MP0009642_abnormal_blood_homeostasis | 0.79613171 |
| 110 | MP0002090_abnormal_vision | 0.79444819 |
| 111 | MP0008469_abnormal_protein_level | 0.78821548 |
| 112 | MP0002163_abnormal_gland_morphology | 0.74815913 |
| 113 | MP0002127_abnormal_cardiovascular_syste | 0.74628702 |
| 114 | MP0008873_increased_physiological_sensi | 0.73883024 |
| 115 | MP0005166_decreased_susceptibility_to | 0.73104080 |
| 116 | MP0001881_abnormal_mammary_gland | 0.72324502 |
| 117 | MP0005058_abnormal_lysosome_morphology | 0.69819376 |
| 118 | MP0009763_increased_sensitivity_to | 0.69278233 |
| 119 | MP0000516_abnormal_urinary_system | 0.67319820 |
| 120 | MP0005367_renal/urinary_system_phenotyp | 0.67319820 |
| 121 | MP0002019_abnormal_tumor_incidence | 0.65403988 |
| 122 | MP0005334_abnormal_fat_pad | 0.65336127 |
| 123 | MP0005165_increased_susceptibility_to | 0.64631334 |
| 124 | MP0003567_abnormal_fetal_cardiomyocyte | 0.61838307 |
| 125 | MP0001853_heart_inflammation | 0.61348453 |
| 126 | MP0000604_amyloidosis | 0.61089839 |
| 127 | MP0000358_abnormal_cell_content/ | 0.57640259 |
| 128 | MP0001765_abnormal_ion_homeostasis | 0.56810863 |
| 129 | MP0003828_pulmonary_edema | 0.56596044 |
| 130 | MP0004145_abnormal_muscle_electrophysio | 0.56304810 |
| 131 | MP0005448_abnormal_energy_balance | 0.56197775 |
| 132 | MP0002970_abnormal_white_adipose | 0.55632372 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.54804041 |
| 134 | MP0000013_abnormal_adipose_tissue | 0.54330904 |
| 135 | MP0003868_abnormal_feces_composition | 0.54117217 |
| 136 | MP0001529_abnormal_vocalization | 0.52736900 |
| 137 | MP0004185_abnormal_adipocyte_glucose | 0.52428131 |
| 138 | MP0003950_abnormal_plasma_membrane | 0.52342660 |
| 139 | MP0004233_abnormal_muscle_weight | 0.51310799 |
| 140 | MP0003953_abnormal_hormone_level | 0.48207864 |
| 141 | MP0004782_abnormal_surfactant_physiolog | 0.48094748 |
| 142 | MP0009764_decreased_sensitivity_to | 0.48079200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.83545571 |
| 2 | Hepatic necrosis (HP:0002605) | 4.81396413 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.69887125 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.69256809 |
| 5 | Acute encephalopathy (HP:0006846) | 4.66866520 |
| 6 | Cerebral edema (HP:0002181) | 4.39076275 |
| 7 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.25823314 |
| 8 | Myoglobinuria (HP:0002913) | 4.17692906 |
| 9 | Hepatocellular necrosis (HP:0001404) | 4.15240950 |
| 10 | Abnormality of glycolysis (HP:0004366) | 4.15044004 |
| 11 | Increased serum pyruvate (HP:0003542) | 4.15044004 |
| 12 | Mitochondrial inheritance (HP:0001427) | 4.04890662 |
| 13 | Ketoacidosis (HP:0001993) | 3.97236691 |
| 14 | Increased CSF lactate (HP:0002490) | 3.94395661 |
| 15 | Hyperammonemia (HP:0001987) | 3.91302662 |
| 16 | Generalized aminoaciduria (HP:0002909) | 3.90652983 |
| 17 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.89970142 |
| 18 | Dicarboxylic aciduria (HP:0003215) | 3.89970142 |
| 19 | Progressive macrocephaly (HP:0004481) | 3.89130289 |
| 20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.86583905 |
| 21 | Ketosis (HP:0001946) | 3.83724477 |
| 22 | Rhabdomyolysis (HP:0003201) | 3.72167081 |
| 23 | Exercise-induced muscle cramps (HP:0003710) | 3.67994153 |
| 24 | Hyperglycinuria (HP:0003108) | 3.62867054 |
| 25 | Increased muscle lipid content (HP:0009058) | 3.61473467 |
| 26 | Hypobetalipoproteinemia (HP:0003563) | 3.48505850 |
| 27 | Lactic acidosis (HP:0003128) | 3.47837316 |
| 28 | Lethargy (HP:0001254) | 3.33454091 |
| 29 | Intrahepatic cholestasis (HP:0001406) | 3.29499239 |
| 30 | Increased intramyocellular lipid droplets (HP:0012240) | 3.26783987 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.26405061 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.24980173 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 3.24980173 |
| 34 | Lipid accumulation in hepatocytes (HP:0006561) | 3.21975579 |
| 35 | Exercise-induced myalgia (HP:0003738) | 3.14881489 |
| 36 | Proximal tubulopathy (HP:0000114) | 3.13356299 |
| 37 | Abnormality of urine glucose concentration (HP:0011016) | 3.07876855 |
| 38 | Glycosuria (HP:0003076) | 3.07876855 |
| 39 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.07622796 |
| 40 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.07622796 |
| 41 | Sudden death (HP:0001699) | 3.06897927 |
| 42 | Metabolic acidosis (HP:0001942) | 3.05758928 |
| 43 | Respiratory failure (HP:0002878) | 3.01604088 |
| 44 | Nausea (HP:0002018) | 2.99933014 |
| 45 | Xanthomatosis (HP:0000991) | 2.99287310 |
| 46 | Exercise intolerance (HP:0003546) | 2.94966683 |
| 47 | Increased serum lactate (HP:0002151) | 2.93651184 |
| 48 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.92978392 |
| 49 | Nemaline bodies (HP:0003798) | 2.90879845 |
| 50 | Type I transferrin isoform profile (HP:0003642) | 2.89498881 |
| 51 | Reduced antithrombin III activity (HP:0001976) | 2.86181720 |
| 52 | * Palpitations (HP:0001962) | 2.84356247 |
| 53 | Calf muscle hypertrophy (HP:0008981) | 2.82829414 |
| 54 | Methylmalonic acidemia (HP:0002912) | 2.82088827 |
| 55 | Vomiting (HP:0002013) | 2.78225428 |
| 56 | Ventricular tachycardia (HP:0004756) | 2.77985009 |
| 57 | Hyperglycinemia (HP:0002154) | 2.77862602 |
| 58 | Aplastic anemia (HP:0001915) | 2.73530033 |
| 59 | Ragged-red muscle fibers (HP:0003200) | 2.73225363 |
| 60 | Exertional dyspnea (HP:0002875) | 2.72803075 |
| 61 | Muscle fiber inclusion bodies (HP:0100299) | 2.71861773 |
| 62 | Increased hepatocellular lipid droplets (HP:0006565) | 2.71607456 |
| 63 | Hypolipoproteinemia (HP:0010981) | 2.71415309 |
| 64 | Deep venous thrombosis (HP:0002625) | 2.69446968 |
| 65 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.64803876 |
| 66 | Prolonged partial thromboplastin time (HP:0003645) | 2.64471376 |
| 67 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.62333579 |
| 68 | 3-Methylglutaconic aciduria (HP:0003535) | 2.60732175 |
| 69 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.58899697 |
| 70 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.57417126 |
| 71 | Gout (HP:0001997) | 2.56035141 |
| 72 | Lipoatrophy (HP:0100578) | 2.53270434 |
| 73 | Abnormality of vitamin B metabolism (HP:0004340) | 2.52885175 |
| 74 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.52414136 |
| 75 | Hyperbilirubinemia (HP:0002904) | 2.50381521 |
| 76 | CNS demyelination (HP:0007305) | 2.50140463 |
| 77 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.42492336 |
| 78 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.39523195 |
| 79 | Hyperlipoproteinemia (HP:0010980) | 2.36106892 |
| 80 | Dilated cardiomyopathy (HP:0001644) | 2.34920996 |
| 81 | Cholelithiasis (HP:0001081) | 2.34541210 |
| 82 | Abnormality of serum amino acid levels (HP:0003112) | 2.34087072 |
| 83 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.32831827 |
| 84 | Abnormal gallbladder morphology (HP:0012437) | 2.32750861 |
| 85 | Methylmalonic aciduria (HP:0012120) | 2.32558989 |
| 86 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.31753546 |
| 87 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.31753546 |
| 88 | Abnormal protein glycosylation (HP:0012346) | 2.31753546 |
| 89 | Abnormal glycosylation (HP:0012345) | 2.31753546 |
| 90 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.28794266 |
| 91 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.27613402 |
| 92 | Hypoalphalipoproteinemia (HP:0003233) | 2.27322276 |
| 93 | Abnormality of purine metabolism (HP:0004352) | 2.26373152 |
| 94 | Cholecystitis (HP:0001082) | 2.26137079 |
| 95 | Abnormal gallbladder physiology (HP:0012438) | 2.26137079 |
| 96 | Renal cortical cysts (HP:0000803) | 2.25548708 |
| 97 | Congenital, generalized hypertrichosis (HP:0004540) | 2.24903878 |
| 98 | Megaloblastic anemia (HP:0001889) | 2.23264701 |
| 99 | Oral leukoplakia (HP:0002745) | 2.22451663 |
| 100 | Abnormality of methionine metabolism (HP:0010901) | 2.22047762 |
| 101 | Late onset (HP:0003584) | 2.20840275 |
| 102 | Respiratory difficulties (HP:0002880) | 2.19288830 |
| 103 | Neoplasm of head and neck (HP:0012288) | 2.19000477 |
| 104 | Esophageal neoplasm (HP:0100751) | 2.19000477 |
| 105 | Leukodystrophy (HP:0002415) | 2.18585671 |
| 106 | Muscle stiffness (HP:0003552) | 2.15437624 |
| 107 | Renal Fanconi syndrome (HP:0001994) | 2.15157240 |
| 108 | Abnormality of the intrinsic pathway (HP:0010989) | 2.14780394 |
| 109 | Pancytopenia (HP:0001876) | 2.14180697 |
| 110 | Hypoglycemic seizures (HP:0002173) | 2.13868591 |
| 111 | Right ventricular cardiomyopathy (HP:0011663) | 2.13026154 |
| 112 | Multiple enchondromatosis (HP:0005701) | 2.12123845 |
| 113 | Abnormality of nucleobase metabolism (HP:0010932) | 2.11708283 |
| 114 | Fat malabsorption (HP:0002630) | 2.10445632 |
| 115 | Abnormality of the anterior horn cell (HP:0006802) | 2.04770765 |
| 116 | Degeneration of anterior horn cells (HP:0002398) | 2.04770765 |
| 117 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.04463166 |
| 118 | Hyperphosphaturia (HP:0003109) | 2.03540864 |
| 119 | Increased purine levels (HP:0004368) | 2.03274887 |
| 120 | Hyperuricemia (HP:0002149) | 2.03274887 |
| 121 | Abnormality of alanine metabolism (HP:0010916) | 2.00172030 |
| 122 | Hyperalaninemia (HP:0003348) | 2.00172030 |
| 123 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.00172030 |
| 124 | Optic disc pallor (HP:0000543) | 1.99490121 |
| 125 | Symptomatic seizures (HP:0011145) | 1.98606552 |
| 126 | Posterior subcapsular cataract (HP:0007787) | 1.93021167 |
| 127 | Vacuolated lymphocytes (HP:0001922) | 1.91361218 |
| 128 | Microvesicular hepatic steatosis (HP:0001414) | 1.90723306 |
| 129 | Paralysis (HP:0003470) | 1.90279628 |
| 130 | Abnormality of renal resorption (HP:0011038) | 1.90054258 |
| 131 | Amniotic constriction ring (HP:0009775) | 1.87673148 |
| 132 | Abnormality of placental membranes (HP:0011409) | 1.87673148 |
| 133 | Abnormality of vitamin metabolism (HP:0100508) | 1.87134043 |
| 134 | Macrocytic anemia (HP:0001972) | 1.81349540 |
| 135 | Steatorrhea (HP:0002570) | 1.81309093 |
| 136 | Abnormality of the labia minora (HP:0012880) | 1.74223486 |
| 137 | Abnormal pupillary function (HP:0007686) | 1.70512228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.62100063 |
| 2 | OBSCN | 4.36954658 |
| 3 | VRK2 | 4.04291145 |
| 4 | MYLK | 3.86580098 |
| 5 | PDK3 | 3.37536130 |
| 6 | PDK4 | 3.37536130 |
| 7 | NEK1 | 3.13121079 |
| 8 | EIF2AK1 | 2.59877598 |
| 9 | PKN2 | 2.56215640 |
| 10 | TTN | 2.28217538 |
| 11 | LMTK2 | 2.20513183 |
| 12 | FLT3 | 1.99054213 |
| 13 | PDK2 | 1.98707641 |
| 14 | NUAK1 | 1.98372638 |
| 15 | PIK3CA | 1.86729262 |
| 16 | NME1 | 1.86493989 |
| 17 | SRPK1 | 1.86162471 |
| 18 | PLK3 | 1.83984001 |
| 19 | TTK | 1.82304967 |
| 20 | NME2 | 1.81113271 |
| 21 | WNK4 | 1.81033447 |
| 22 | STK24 | 1.78831000 |
| 23 | TRIM28 | 1.66840361 |
| 24 | STK16 | 1.59635032 |
| 25 | TRIB3 | 1.51596943 |
| 26 | PIK3CG | 1.50841003 |
| 27 | MAP3K3 | 1.48631908 |
| 28 | STK38L | 1.46274392 |
| 29 | MKNK2 | 1.41883719 |
| 30 | PBK | 1.41745133 |
| 31 | INSRR | 1.41684780 |
| 32 | PLK4 | 1.41619053 |
| 33 | PHKG2 | 1.37956033 |
| 34 | PHKG1 | 1.37956033 |
| 35 | MAP2K3 | 1.32293890 |
| 36 | ABL2 | 1.32255431 |
| 37 | MKNK1 | 1.32088658 |
| 38 | BMPR1B | 1.31269359 |
| 39 | CDC7 | 1.30305278 |
| 40 | ERBB3 | 1.24930463 |
| 41 | KDR | 1.24910736 |
| 42 | EIF2AK3 | 1.22019729 |
| 43 | NEK9 | 1.18081064 |
| 44 | MST1R | 1.15477251 |
| 45 | MST4 | 1.13172497 |
| 46 | ZAK | 1.12986528 |
| 47 | FRK | 1.12269451 |
| 48 | TAF1 | 1.09661616 |
| 49 | EIF2AK2 | 1.08373692 |
| 50 | LIMK1 | 1.07990158 |
| 51 | ERN1 | 1.05978332 |
| 52 | PINK1 | 1.05833331 |
| 53 | MUSK | 1.04390429 |
| 54 | WNK3 | 1.04066568 |
| 55 | ILK | 1.01705301 |
| 56 | GRK1 | 1.01043805 |
| 57 | BUB1 | 1.00643868 |
| 58 | ACVR1B | 0.94366201 |
| 59 | TESK1 | 0.93040567 |
| 60 | TNIK | 0.92132657 |
| 61 | PLK1 | 0.90189850 |
| 62 | MAP3K12 | 0.89538381 |
| 63 | TIE1 | 0.87603204 |
| 64 | MAP3K11 | 0.86560275 |
| 65 | ERBB4 | 0.82572111 |
| 66 | SIK1 | 0.82329982 |
| 67 | ARAF | 0.79098233 |
| 68 | DAPK1 | 0.78506621 |
| 69 | STK4 | 0.76838218 |
| 70 | ADRBK2 | 0.75236361 |
| 71 | SCYL2 | 0.74980167 |
| 72 | MAP4K2 | 0.74226930 |
| 73 | STK10 | 0.72178921 |
| 74 | STK3 | 0.70822785 |
| 75 | MAPKAPK5 | 0.70081245 |
| 76 | TXK | 0.69836786 |
| 77 | PIM2 | 0.69124990 |
| 78 | TYK2 | 0.68829546 |
| 79 | MAPK11 | 0.66943969 |
| 80 | MAP2K6 | 0.66933831 |
| 81 | PRKG2 | 0.65615430 |
| 82 | TRPM7 | 0.64925704 |
| 83 | MAPKAPK3 | 0.64016214 |
| 84 | GRK7 | 0.63829269 |
| 85 | OXSR1 | 0.62350753 |
| 86 | PASK | 0.61795939 |
| 87 | VRK1 | 0.61366309 |
| 88 | BRSK2 | 0.61184315 |
| 89 | DAPK3 | 0.60491930 |
| 90 | MAPK12 | 0.60209138 |
| 91 | MAP3K5 | 0.60050482 |
| 92 | MAP2K4 | 0.59744184 |
| 93 | CSNK1G3 | 0.59122292 |
| 94 | CSNK1G1 | 0.58483537 |
| 95 | TEC | 0.55837340 |
| 96 | FGFR4 | 0.54804559 |
| 97 | LRRK2 | 0.54289274 |
| 98 | NLK | 0.53636647 |
| 99 | PRKAA2 | 0.53519044 |
| 100 | CCNB1 | 0.51919092 |
| 101 | STK39 | 0.51012384 |
| 102 | WEE1 | 0.50006057 |
| 103 | CAMK2D | 0.49230671 |
| 104 | PRKACG | 0.49198374 |
| 105 | TBK1 | 0.47750050 |
| 106 | CAMK2G | 0.47672629 |
| 107 | PRKAA1 | 0.47326298 |
| 108 | CSNK2A2 | 0.46969306 |
| 109 | BRSK1 | 0.46077008 |
| 110 | TESK2 | 0.45196750 |
| 111 | IRAK3 | 0.43851213 |
| 112 | ALK | 0.42512041 |
| 113 | PLK2 | 0.40784626 |
| 114 | BMPR2 | 0.40465435 |
| 115 | BCR | 0.39410178 |
| 116 | MAP2K1 | 0.38838355 |
| 117 | CSNK2A1 | 0.37439606 |
| 118 | CSNK1G2 | 0.36697352 |
| 119 | ATR | 0.35311685 |
| 120 | PRKACA | 0.35219076 |
| 121 | PAK3 | 0.35043460 |
| 122 | CSNK1A1L | 0.34232080 |
| 123 | TSSK6 | 0.34132673 |
| 124 | GRK6 | 0.33739549 |
| 125 | TGFBR1 | 0.33557174 |
| 126 | RPS6KC1 | 0.32535720 |
| 127 | RPS6KL1 | 0.32535720 |
| 128 | MAPK4 | 0.31702292 |
| 129 | RPS6KB2 | 0.30696903 |
| 130 | RPS6KA6 | 0.29836452 |
| 131 | JAK2 | 0.29796503 |
| 132 | CLK1 | 0.29367931 |
| 133 | SIK3 | 0.29233844 |
| 134 | AURKB | 0.28867363 |
| 135 | PRKACB | 0.28741351 |
| 136 | MET | 0.28465530 |
| 137 | CHEK2 | 0.27393827 |
| 138 | MAP3K8 | 0.26064182 |
| 139 | FER | 0.25544332 |
| 140 | PAK4 | 0.25289149 |
| 141 | PRKCI | 0.24965164 |
| 142 | CDK8 | 0.24961035 |
| 143 | PTK6 | 0.24944356 |
| 144 | PRKCD | 0.24880240 |
| 145 | TAOK3 | 0.24140443 |
| 146 | TLK1 | 0.23382434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.14858279 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.35299890 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.15476296 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.94050569 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.93144047 |
| 6 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.86656485 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.84762687 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.78961377 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.62364881 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.41655384 |
| 11 | * Carbon metabolism_Homo sapiens_hsa01200 | 2.33080514 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.24556216 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.19686355 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12767349 |
| 15 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.10298622 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.07755953 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.98751007 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.98136927 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.93903806 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.89967113 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.86341136 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.85223237 |
| 23 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.80470420 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.75031125 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.74528906 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.74000380 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.70250394 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.65857454 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.63653978 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.61131551 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.56812958 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.54280628 |
| 33 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.53877174 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.49412464 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.49229791 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44385003 |
| 37 | Proteasome_Homo sapiens_hsa03050 | 1.43458051 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.43182974 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32587714 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29102445 |
| 41 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.27895184 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.27536389 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21359685 |
| 44 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.20553102 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.19017189 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.17857182 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16005737 |
| 48 | Basal transcription factors_Homo sapiens_hsa03022 | 1.13780206 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10006533 |
| 50 | RNA degradation_Homo sapiens_hsa03018 | 1.08589393 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05010897 |
| 52 | Base excision repair_Homo sapiens_hsa03410 | 1.04614667 |
| 53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.04571787 |
| 54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04101347 |
| 55 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03226544 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02440678 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.01425691 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00849771 |
| 59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97413188 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96151838 |
| 61 | RNA transport_Homo sapiens_hsa03013 | 0.95269861 |
| 62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94451108 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94444108 |
| 64 | Spliceosome_Homo sapiens_hsa03040 | 0.91334960 |
| 65 | Protein export_Homo sapiens_hsa03060 | 0.90991346 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.86873558 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84880152 |
| 68 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84069389 |
| 69 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.82139303 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81826177 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79321301 |
| 72 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76372190 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.72431125 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.72254865 |
| 75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.70401466 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.69246321 |
| 77 | Bile secretion_Homo sapiens_hsa04976 | 0.64629168 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.62924850 |
| 79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.61775993 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61328751 |
| 81 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.60317689 |
| 82 | Ribosome_Homo sapiens_hsa03010 | 0.58493572 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.57270745 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56601031 |
| 85 | Asthma_Homo sapiens_hsa05310 | 0.52820612 |
| 86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50454860 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49354407 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45497573 |
| 89 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.45339763 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.43631800 |
| 91 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.43004746 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.42560466 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.40808601 |
| 94 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40785895 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39638643 |
| 96 | Cell cycle_Homo sapiens_hsa04110 | 0.38201857 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.37881896 |
| 98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36626544 |
| 99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33952698 |
| 100 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.32875736 |
| 101 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31807392 |
| 102 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.30429116 |
| 103 | Lysine degradation_Homo sapiens_hsa00310 | 0.29910024 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26006397 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21050404 |
| 106 | RNA polymerase_Homo sapiens_hsa03020 | 0.20944051 |
| 107 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.20345537 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.19458545 |
| 109 | DNA replication_Homo sapiens_hsa03030 | 0.18706663 |
| 110 | Purine metabolism_Homo sapiens_hsa00230 | 0.17265341 |
| 111 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.15644885 |
| 112 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.12832337 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.12667774 |
| 114 | Legionellosis_Homo sapiens_hsa05134 | 0.12317869 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.07072148 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06829472 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.05779302 |
| 118 | Mismatch repair_Homo sapiens_hsa03430 | 0.04966265 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.01344830 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.00759121 |

